Article Versions Notes

Wang L, Liu F, Li J, Ma L, Feng H, Liu Q, Cho WC, Chen H, Chen H, Guo H, et al. From Anti-PD-1/PD-L1 to CTLA-4 and to MUC1—Is the Better Response to Treatment in Smokers of Cancer Patients Drug Specific? Journal of Personalized Medicine. 2021; 11(9):914. https://doi.org/10.3390/jpm11090914

Wang, Lishi, Fengxia Liu, Jing Li, Li Ma, Helin Feng, Qingyi Liu, William C. Cho, Haiyong Chen, Hong Chen, Hua Guo, and et al. 2021. "From Anti-PD-1/PD-L1 to CTLA-4 and to MUC1—Is the Better Response to Treatment in Smokers of Cancer Patients Drug Specific?" Journal of Personalized Medicine 11, no. 9: 914. https://doi.org/10.3390/jpm11090914

Wang, L., Liu, F., Li, J., Ma, L., Feng, H., Liu, Q., Cho, W. C., Chen, H., Chen, H., Guo, H., Li, Z., Howard, S. C., Li, M., Shan, B., Gu, W., & Ji, J. (2021). From Anti-PD-1/PD-L1 to CTLA-4 and to MUC1—Is the Better Response to Treatment in Smokers of Cancer Patients Drug Specific? Journal of Personalized Medicine, 11(9), 914. https://doi.org/10.3390/jpm11090914